Harold Burstein, MD, PhD on advances in breast cancer research from ASCO 2022

Breast cancer highlights from the 2022 ASCO Annual Meeting | Harold BursteinПодробнее

Recent Advances and Future Directions in Breast Cancer — With Dr Harold Burstein and Dr Virginia ...Подробнее

Harold J. Burstein, MD, PhD, on breast cancer treatment | Dana-Farber Cancer InstituteПодробнее

Optimizing Adjuvant Therapy ThroughGenomics Dr. Harold Burstein Day 1Подробнее

Advances in Breast Cancer ResearchПодробнее

An Insider's Look: Innovations in Breast Cancer ResearchПодробнее

Dr. Burstein on the Treatment Landscape of HER2+ Breast CancerПодробнее

278 ‒ Breast cancer: how to catch, treat, and survive breast cancer | Harold Burstein, M.D., Ph.D.Подробнее

2021 San Antonio Breast Cancer Symposium Update on MBC | 2021-2022 EMBRACE MBC Virtual Forum SeriesПодробнее

How to treat HER2+ Breast Cancer in 2024 with Dr. Harold BursteinПодробнее

Advances in breast cancer coming in 2021Подробнее

Meet Breast Cancer Specialist Wade Smith, M.D. | City of Hope Orange CountyПодробнее

Breast cancer: new advances in personalized medicine and therapeuticsПодробнее

What is Neoadjuvant Therapy? | Dana-Farber Cancer InstituteПодробнее

Key takeaways from ASCO 2022Подробнее

Does Pregnancy Reduce the Risk of Developing Breast or Gynecologic Cancers?Подробнее

Navigating the treatment for breast cancer | Peter Attia & Harold BursteinПодробнее

Dr. Harold J. Burstein on CDK4/CDK6 Inhibitor Abemaciclib in Breast CancerПодробнее

Latest advances in breast cancer researchПодробнее

Dr. Burstein on the Follow-Up of APT Trial for HER2+ Breast CancerПодробнее